{"code":"E72.5","type":"code","title":"Disorders of glycine metabolism","codeAlso":[],"includes":[],"modern_v":"official26","codeFirst":[],"excludes1":["disorders of:","aromatic amino-acid metabolism (E70.-)","branched-chain amino-acid metabolism (E71.0-E71.2)","fatty-acid metabolism (E71.3)","purine and pyrimidine metabolism (E79.-)","gout (M1A.-, M10.-)","androgen insensitivity syndrome (E34.5-)","congenital adrenal hyperplasia (E25.0)","hemolytic anemias attributable to enzyme disorders (D55.-)","Marfan syndrome (Q87.4-)","5-alpha-reductase deficiency (E29.1)"],"excludes2":["Ehlers-Danlos syndromes (Q79.6-)"],"isBillable":false,"fyEffectivity":{"fy2026":true,"fy2027":true,"billableFy2026":false,"billableFy2027":false},"sibling_codes":["E72.50","E72.51","E72.52","E72.53","E72.530","E72.538","E72.539","E72.54","E72.540","E72.541","E72.548","E72.549","E72.59"],"inclusionTerms":[],"sibling_titles":{"code":"E72.59","title":"Other disorders of glycine metabolism","isBillable":true},"useAdditionalCode":[],"clinicalDefinition":"Disorders of glycine metabolism is a non-billable ICD-10-CM category code (E72.5). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): disorders of:; aromatic amino-acid metabolism (E70.-); branched-chain amino-acid metabolism (E71.0-E71.2); fatty-acid metabolism (E71.3); purine and pyrimidine metabolism (E79.-); gout (M1A.-, M10.-); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.","officialDefinition":"Disorders of glycine metabolism is a non-billable ICD-10-CM category code (E72.5). A more specific billable subcode must be selected for claims submission. Excludes1 (not coded here): disorders of:; aromatic amino-acid metabolism (E70.-); branched-chain amino-acid metabolism (E71.0-E71.2); fatty-acid metabolism (E71.3); purine and pyrimidine metabolism (E79.-); gout (M1A.-, M10.-); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); hemolytic anemias attributable to enzyme disorders (D55.-); Marfan syndrome (Q87.4-); 5-alpha-reductase deficiency (E29.1). Excludes2 (not included here): Ehlers-Danlos syndromes (Q79.6-).","seventhCharacterInstructions":[],"workflowProtocols":[],"guidelines":{"whenToUse":[],"whenNotToUse":[],"commonBillingMistakes":[],"codeComparisons":[],"documentationChecklist":[]},"domainLandscape":{"summary":"Primary diagnostic domain and clinical landscape evaluation.","keyCategories":[],"diagnosticContinuum":"Progression continuum from acute presentation to resolution."},"children":[],"hierarchy":[],"relatedCodes":[],"relevantCPTCodes":[],"documentationTips":[],"caseStudies":[],"description":"","overview":""}